ORMP ORAMED PHARMACEUTICALS INC.
Healthcare · Pharmaceutical Preparations · Market cap: $161.3M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $94.1K |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $395.7K | $368.2K |
| 2023-Q2 | $19.5K | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $942.2K |
| 2026-Q4 | $0 | $225.5K |
Bought$415.3K6 buy days
Sold$1.6M7 sell days
Net insider flow-$1.2Mnet selling · 5 years
Latest trade2026-10-01Hexter Joshua
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Sell | Hexter Joshua | COO | 30,000 | $4.51 | $135.3K | 1 |
| 2026-10-01 | Sell | Gabay Avraham | CFO | 20,000 | $4.51 | $90.2K | 1 |
| 2026-07-01 | Sell | Hexter Joshua | COO | 137,000 | $4.46 | $611.4K | 1 |
| 2026-07-01 | Sell | Gabay Avraham | CFO | 73,360 | $4.51 | $330.7K | 1 |
| 2023-04-04 | Buy | Mayer Arie | Director | 3,800 | $2.21 | $8.4K | 1 |
| 2023-04-03 | Buy | Mayer Arie | Director | 5,009 | $2.22 | $11.1K | 1 |
| 2023-03-16 | Buy | KIDRON NADAV | CEO | 26,000 | $2.04 | $53.0K | 1 |
| 2023-03-14 | Sell | Kidron Miriam | Other C-suite | 100,000 | $2.01 | $201.0K | 1 |
| 2023-03-14 | Buy | KIDRON NADAV | CEO | 100,000 | $2.01 | $201.0K | 1 |
| 2023-03-14 | Buy | Rozov Yadin | Director | 50,000 | $2.05 | $102.5K | 1 |
| 2023-03-13 | Buy | Rozov Yadin | Director | 20,000 | $1.96 | $39.2K | 1 |
| 2023-01-03 | Sell | Rabinowitz Michael | Other C-suite | 13,325 | $12.55 | $167.2K | 2 |
| 2022-03-21 | Sell | RAKIN KEVIN | Director | 10,000 | $9.41 | $94.1K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Hexter Joshua | COO | $0 | $746.8K | 2026-10-01 |
| Gabay Avraham | CFO | $0 | $420.9K | 2026-10-01 |
| KIDRON NADAV | CEO | $254.0K | $0 | 2023-03-16 |
| Kidron Miriam | Other C-suite | $0 | $201.0K | 2023-03-14 |
| Rabinowitz Michael | Other C-suite | $0 | $167.2K | 2023-01-03 |
| Rozov Yadin | Director | $141.7K | $0 | 2023-03-14 |
| RAKIN KEVIN | Director | $0 | $94.1K | 2022-03-21 |
| Mayer Arie | Director | $19.5K | $0 | 2023-04-04 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2023-03-13 → 2023-04-04 | 3 | $415.3K | 56 | +26.8% (+26.9% raw) | +52.2% (+58.4% raw) | +10.1% (+9.1% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.